Cartalax
Cartalax (AED Peptide) – 20mg lyophilized powder, ≥99% purity (HPLC verified). A synthetic tripeptide bioregulator (Ala-Glu-Asp) researched for its role in chondrocyte gene expression regulation and connective tissue remodeling pathways. Third-party tested for identity and purity. For research use only.
Overview:
Cartalax is a synthetic tripeptide bioregulator composed of alanine, glutamic acid, and aspartic acid, developed through research at the St. Petersburg Institute of Bioregulation and Gerontology. This compound is being examined in experimental research settings for its role in chondrocyte gene expression regulation, extracellular matrix maintenance, and connective tissue remodeling pathways under controlled laboratory conditions.
Specifications:
- Unit Size: 20mg (vial format)
- Purity: ≥99% (HPLC verified)
- Form: Lyophilized powder
- Molecular Formula: C₁₂H₁₉N₃O₈
- Molecular Weight: 333.29 g/mol
- Sequence: Ala-Glu-Asp (AED)
- Storage: Keep in a cool, dry environment. For optimal longevity, store reconstituted material between 2°C–8°C.
For laboratory and research use only. Not for human consumption.
This product is not intended to diagnose, treat, cure, or prevent any disease. These statements have not been evaluated by the Food and Drug Administration.
Vial size: Supplied in a 3mL vial.
Research Use Only
This product is intended for laboratory and research purposes only. Not intended for human or animal consumption, therapeutic use, or any form of in-vivo application. By purchasing, you confirm you are a qualified researcher and will use products in accordance with all applicable laws and regulations.
